Additional file 6 of Guadecitabine increases response to combined anti-CTLA-4 and anti-PD-1 treatment in mouse melanoma in vivo by controlling T-cells, myeloid derived suppressor and NK cells

Additional file 6: Supplementary Table 1. List of the 334 genes identified by 103 probes using the most variable 1% of probes differentially methylated between the tumors from mice treated with guadecitabine compared to those without guadecitabine.

附加文件6：补充表1。本列表收录了通过103个探针（probe）鉴定得到的334个基因；前述探针取自接受格拉西他滨（guadecitabine）治疗的小鼠肿瘤与未接受该药物治疗的小鼠肿瘤之间差异甲基化的探针集合中，变异程度最高的1%子集。